AMS Settles With Celsion Over Prostate Product

Law360, New York (February 8, 2007, 12:00 AM EST) -- American Medical Systems Inc. has settled a lawsuit in which it accused biotechnology company Celsion Corp. of infringing its patents on a prostate enlargement treatment.

Under the terms of the settlement, which was announced Thursday, Celsion will pay AMS a licensing fee and ongoing royalty payments. In return, AMS will drop the suit, and Celsion will continue selling its Prolieve product in the United States.

The financial terms of the deal remain undisclosed.

“Intellectual property fuels the engine of [our] pelvic health innovation,” said Ross Longhini,...
To view the full article, register now.